Fredun Pharmaceuticals bonus shares: history and record dates
NSE: FREDUNBSE: 539730Pharmaceuticals & BiotechnologySmall Cap
Fredun Pharmaceuticals Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Mar 2016
Last close ₹1,367.00down ₹86.50 (5.95%)BSE ₹1,366.05
Share price at the NSE close on 30 Oct 2026. Previous close ₹1,453.50.
30 Oct: open ₹1,455.00, high ₹1,467.90, low ₹1,360.00
52-week range of BSE trades to 30 Oct 2026
₹454.05Low, 12 Jan 2026₹1,666.35High, 8 Oct 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹2,310 Cr1,474th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 8.31
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.02%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 18.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.80
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 53,67255.3% delivered
Fredun Pharmaceuticals' one bonus issue since Mar 2016, gone ex on 16 Jul 2026, with its ratio, ex-date and record date and what one share held before it became.
What one share became
Neither changes what a holding is worth on the day.Fredun Pharmaceuticals dividend history
One share held before 16 Jul 20263 shares todayShares today for one share held before. One share multiplied by the share factor of this bonus or split and of every one after it: a 1:1 bonus doubles the count, and a split of a ₹10 share into ₹2 shares multiplies it by five. Shares today for one share held before in the glossary
- Bonus issues
- 1
Bonus issues: ratio, ex-date and record date
A bonus issue gives holders free extra shares in a fixed ratio. On record from 2007.All upcoming bonus issues
Shares today for one held before the ex-date, after every event since
- 16 Jul 2026 · ex-date2 for 1 bonusRecord date 16 Jul 20263 shares todayfor 1 held before 16 Jul 2026